Answer
Yes, hypersensitivity to previous irinotecan therapy is a contraindication to Trodelvy (sacituzumab govitecan).
Sources for this answer
- Trodelvy 180 mg powder for concentrate for solution for infusionGilead Sciences Ltd · emc · SmPC §4.3 Contraindications · Version 10Document updated
Sources checked